Health-Related Quality of Life Reported Among Patients with Paroxysmal Nocturnal Hemoglobinuria: Impact of Treatment with Pegcetacoplan and C5-Inhibitors
Year: 2022
Type: article
Study design: Observational Study
Source: Blood
Authors: Dharmik Desai, Nandini Hadker, Amanda Francis, Amanda Cassidy Torres, Laura Hill, Jed Perler, David Dingli
Institutions: Apellis Pharmaceuticals (United States), Mayo Clinic
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4310103252